Opdivo, Twitter, 7/4/2019 10:45:31 PM, 202137


FAQ | Problem?

Opdivo_2019-07-04_15-02-19.xlsx
Opdivo_2019-07-04_15-02-19.xlsx
From:
NodeXLExcelAutomator
Uploaded on:
July 04, 2019
Short Description:
Opdivo via NodeXL http://bit.ly/2YvMxCZ
@satoruo
@bmsnews
@lucidhealthcon
@adamfeuerstein
@infocancerfoie
@gambiste1
@augustonyc
@mvas52
@jacobplieth
@bclc_group

Top hashtags:
#opdivo
#nivolumab
#zoladex
#rituximab
#avastin
#nexavar
#caracas
#sutent
#sorafenib

Description:
Description
The graph represents a network of 1,089 Twitter users whose tweets in the requested range contained "Opdivo", or who were replied to or mentioned in those tweets. The network was obtained from the NodeXL Graph Server on Thursday, 04 July 2019 at 22:06 UTC.

The requested start date was Thursday, 04 July 2019 at 00:01 UTC and the maximum number of tweets (going backward in time) was 5,000.

The tweets in the network were tweeted over the 58-day, 18-hour, 3-minute period from Wednesday, 01 May 2019 at 00:44 UTC to Friday, 28 June 2019 at 18:47 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 1089
Unique Edges : 1088
Edges With Duplicates : 711
Total Edges : 1799
Number of Edge Types : 3
Mentions : 1096
Tweet : 570
Replies to : 133
Self-Loops : 570
Reciprocated Vertex Pair Ratio : 0.00857449088960343
Reciprocated Edge Ratio : 0.0170031880977683
Connected Components : 312
Single-Vertex Connected Components : 227
Maximum Vertices in a Connected Component : 189
Maximum Edges in a Connected Component : 407
Maximum Geodesic Distance (Diameter) : 13
Average Geodesic Distance : 3.634169
Graph Density : 0.000794205423216118
Modularity : 0.570007
NodeXL Version : 1.0.1.413

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[28] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[13] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[12] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews
[10] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[10] https://twitter.com/BrazilSFE
[10] http://benzaiten.dyndns.org/roller/ugya/entry/honjo-tasuku-opdivo
[9] https://medcitynews.com/2019/05/bmss-immunotherapy-drug-opdivo-fails-in-phase-iii-brain-cancer-study/
[7] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[7] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/
[7] http://cn.nikkei.com/politicsaeconomy/politicsasociety/35516-2019-05-10-10-46-48.html

Top URLs in Tweet in G1:
[12] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews
[10] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[10] https://twitter.com/BrazilSFE
[6] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[5] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews&utm_source=dlvr.it&utm_medium=twitter
[5] https://medcitynews.com/2019/05/bmss-immunotherapy-drug-opdivo-fails-in-phase-iii-brain-cancer-study/
[5] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[4] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8
[4] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter
[4] https://lungcancersymptomsx.com/a-hope-for-mesothelioma-patients-with-new-lung-cancer-drug-opdivo.html

Top URLs in Tweet in G2:
[1] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter

Top URLs in Tweet in G5:
[4] https://news.bms.com/press-release/asco19/bristol-myers-squibb-announces-first-presentation-results-opdivo-nivolumab-plus?linkId=68472488
[3] https://pharmaphorum.com/views-and-analysis/rd-roundup-novartis-crispr-opdivo/
[3] https://finance.yahoo.com/news/bristol-myers-bmy-presents-multiple-130301742.html
[2] http://www.pharmatimes.com/news/bms_opdivo_disappoints_in_late-stage_trial_1292613
[2] https://pharmaphorum.com/news/bms-has-another-opdivo-setback-after-liver-cancer-trial-failure/?utm_source=pharmaphorum+Daily+Newsletter&utm_campaign=e64cb98ac2-EMAIL_CAMPAIGN_2019_06_25_11_55&utm_medium=email&utm_term=0_a54496134b-e64cb98ac2-438901029
[2] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[2] http://www.pharmatimes.com/news/imfinzi,_opdivo_among_latest_smc_decisions_1290505
[2] https://medcitynews.com/2019/06/nektars-bempeg-shows-encouraging-phase-ii-data-in-first-line-melanoma-with-bms-opdivo/
[1] https://www.businesswire.com/news/home/20181209005013/en/Bristol-Myers-Squibb-Vedanta-Biosciences-Announce-New-Clinical
[1] https://pharmaphorum.com/news/bms-opdivo-fails-late-stage-brain-cancer-test/

Top URLs in Tweet in G6:
[15] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[4] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[3] https://bit.ly/2x70MSX
[1] https://twitter.com/InfoCancerFoie/status/1143217317888823296
[1] https://clinicaltrials.gov/ct2/show/NCT02576509?term=nivolumab+checkmate&cond=Hepatocellular+Carcinoma&rank=3

Top URLs in Tweet in G7:
[2] https://seekingalpha.com/news/3473157
[2] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/
[2] https://twitter.com/bio_clouseau/status/1143111436241162241
[1] http://clincancerres.aacrjournals.org/content/early/2019/06/25/1078-0432.CCR-18-3944
[1] http://ir.exelixis.com/news-releases/news-release-details/exelixis-initiating-phase-3-pivotal-trial-cosmic-313
[1] https://news.bms.com/press-release/corporatefinancial-news/five-year-survival-observed-longest-follow-date-advanced-melan
[1] https://www.has-sante.fr/portail/jcms/c_2897014/fr/opdivo-nivolumab-anticorps-monoclonal
[1] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[1] http://dlvr.it/R6ZCZH
[1] http://dlvr.it/R79qzQ

Top URLs in Tweet in G8:
[2] https://www.fiercebiotech.com/biotech/complete-response-rate-nektar-melanoma-trial-hits-34
[1] https://www.businesswire.com/news/home/20190603005209/en/Bristol-Myers-Squibb-Announces-Presentation-Results-Opdivo-nivolumab#.XPT-J7nQVxk.twitter
[1] https://twitter.com/bradloncar/status/1141689484028928001
[1] http://ir.beigene.com/news-releases/news-release-details/beigene-regains-full-global-rights-its-investigational-anti-pd-1
[1] http://dlvr.it/R6lvY5
[1] https://twitter.com/fezziwig2008/status/1062044527438057477
[1] https://clinicaltrials.gov/ct2/show/NCT03656718?term=Rhuph20&draw=2&rank=23
[1] https://twitter.com/fezziwig2008/status/1139975380109074432?s=21
[1] https://www.businesswire.com/news/home/20190517005520/en
[1] https://twitter.com/NewsFromBW/status/1126443362767081472

Top URLs in Tweet in G10:
[1] https://www.opdivo.jp/drug_info_files/drug_info/opdivo/info/21000218/OPD_oshirase_201905.pdf
[1] https://www.nikkei.com/article/DGXMZO44583610Z00C19A5CR8000/

Top Domains
Top Domains in Tweet in Entire Graph:
[43] bms.com
[39] fiercepharma.com
[36] twitter.com
[26] reuters.com
[23] dlvr.it
[22] medcitynews.com
[17] co.jp
[12] blogspot.com
[11] seekingalpha.com
[11] com.br

Top Domains in Tweet in G1:
[24] reuters.com
[19] fiercepharma.com
[16] twitter.com
[15] medcitynews.com
[12] dlvr.it
[11] com.br
[10] co.jp
[9] blogspot.com
[7] einnews.com
[7] bms.com

Top Domains in Tweet in G2:
[1] buzzfeed.com

Top Domains in Tweet in G5:
[8] pharmaphorum.com
[7] bms.com
[5] pharmatimes.com
[3] pharmaceutical-technology.com
[3] yahoo.com
[3] medcitynews.com
[2] pharmashots.com
[2] twitter.com
[1] businesswire.com
[1] drugdevelopment-technology.com

Top Domains in Tweet in G6:
[19] bms.com
[3] bit.ly
[1] twitter.com
[1] clinicaltrials.gov

Top Domains in Tweet in G7:
[3] bms.com
[3] endpts.com
[3] twitter.com
[2] seekingalpha.com
[2] dlvr.it
[1] aacrjournals.org
[1] exelixis.com
[1] has-sante.fr

Top Domains in Tweet in G8:
[4] twitter.com
[2] businesswire.com
[2] fiercebiotech.com
[1] beigene.com
[1] dlvr.it
[1] clinicaltrials.gov

Top Domains in Tweet in G10:
[1] opdivo.jp
[1] nikkei.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[129] opdivo
[77] nivolumab
[47] zoladex
[46] rituximab
[46] avastin
[38] nexavar
[35] caracas
[26] sutent
[25] sorafenib
[24] capecitabina



Top Hashtags in Tweet in G1:
[35] opdivo
[12] januvia
[12] lantus
[12] prevnar13
[12] neulasta
[10] nivolumab
[10] janumet
[10] prevener
[10] peglasta
[10] neupogen

Top Hashtags in Tweet in G3:
[54] opdivo
[47] zoladex
[46] rituximab
[44] nivolumab
[37] nexavar
[35] caracas
[32] avastin
[24] capecitabina
[23] docetaxel
[22] xeloda

Top Hashtags in Tweet in G5:
[8] melanoma
[6] hcc
[5] pharma
[5] media
[5] asco19
[4] pharmanews
[4] opdivo
[3] trial
[3] clinicaltrial
[2] cancer

Top Hashtags in Tweet in G6:
[6] hcc
[5] hepatocellularcarcinoma
[5] livercancer
[5] treatment
[3] pressrelease
[2] nivolumab
[2] sorafenib
[1] media

Top Hashtags in Tweet in G7:
[6] nivolumab
[3] carcinome
[2] sorafenib
[1] chimiothérapie
[1] cetuximab
[1] cabozantinib
[1] ipilimumab
[1] asco2019
[1] mélanome
[1] fails

Top Hashtags in Tweet in G8:
[5] asco19
[2] opdivo
[1] fail
[1] rcc
[1] prostatecancer
[1] melanoma
[1] nivolumab
[1] keytruda
[1] ici

Top Words
Top Words in Tweet in Entire Graph:
[599] Words in Sentiment List#1: Positive
[749] Words in Sentiment List#2: Negative
[2] Words in Sentiment List#3: Angry/Violent
[25506] Non-categorized Words
[26854] Total Words
[858] opdivo
[267] cancer
[246] bristol
[245] nivolumab
[187] がんと免疫については

Top Words in Tweet in G1:
[321] opdivo
[146] cancer
[146] bristol
[96] fails
[84] myers
[84] trial
[80] brain
[76] phase
[74] study
[69] nivolumab

Top Words in Tweet in G2:
[187] がんと免疫については
[187] 以前にバズフィードに解説記事を書いています
[187] 免疫はたしかにがん治療に重要なのですが
[187] それを一般生活にある食品
[187] 食事療法などで
[187] 大きく変えて
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] 記事をご参考に
[186] satoruo

Top Words in Tweet in G3:
[54] #opdivo
[47] #zoladex
[46] #rituximab
[44] #nivolumab
[41] serviciopublive
[39] medcancervzla
[37] #nexavar
[36] ayudasosvzla
[35] #caracas
[34] donamed_ve

Top Words in Tweet in G4:
[62] bir
[61] 2
[60] barisyarkadas
[60] kutusu
[60] 28
[60] bin
[60] tl'den
[60] satılan
[60] ve
[60] ay

Top Words in Tweet in G5:
[42] opdivo
[29] bmsnews
[10] phase
[9] data
[9] patients
[9] study
[8] nivolumab
[8] #melanoma
[7] cancer
[7] bristol

Top Words in Tweet in G6:
[48] sorafenib
[47] nivolumab
[34] survival
[32] improve
[23] trial
[22] results
[22] checkmate
[22] 459
[21] overall
[19] show

Top Words in Tweet in G7:
[54] opdivo
[49] bmy
[27] fails
[24] line
[22] cm
[17] cancer
[17] adamfeuerstein
[15] 1st
[15] glioblastoma
[14] nexavar

Top Words in Tweet in G8:
[42] opdivo
[26] bmy
[14] 1
[13] announces
[13] line
[13] pd
[13] better
[11] first
[11] results
[11] yervoy

Top Words in Tweet in G9:
[3] vprasadmdmph
[3] opdivo
[2] drugs
[2] before
[2] pd
[2] new
[2] bristol

Top Words in Tweet in G10:
[18] オプジーボの副作用報道
[18] 従来も記載
[18] 認識されていた下垂体機能障害を
[18] 重大な副作用
[18] に格上げしたものであり
[18] その頻度の低さ
[18] 適切に検査で発見し処置可能であることを考えれば
[18] その効果を天秤に計ると騒ぎすぎだと感じます
[17] biotechmania

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[187] がんと免疫については,以前にバズフィードに解説記事を書いています
[187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが
[187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品
[187] それを一般生活にある食品,食事療法などで
[187] 食事療法などで,大きく変えて
[187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に
[186] satoruo,がんと免疫については
[159] bristol,myers
[137] opdivo,fails

Top Word Pairs in Tweet in G1:
[87] opdivo,fails
[84] bristol,myers
[74] brain,cancer
[58] opdivo,nivolumab
[57] late,stage
[54] cancer,trial
[53] stage,brain
[52] bristol,myers'
[51] myers',opdivo
[48] myers,squibb

Top Word Pairs in Tweet in G2:
[187] がんと免疫については,以前にバズフィードに解説記事を書いています
[187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが
[187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品
[187] それを一般生活にある食品,食事療法などで
[187] 食事療法などで,大きく変えて
[187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に
[186] satoruo,がんと免疫については

Top Word Pairs in Tweet in G3:
[30] #opdivo,#nivolumab
[23] #rituximab,#capecitabina
[22] #caracas,#rituximab
[22] #capecitabina,#xeloda
[22] #xeloda,#taxol
[22] #taxol,#nexavar
[22] #nexavar,#zoldonat
[22] #zoldonat,#zoladex
[22] #zoladex,#opdivo
[22] #nivolumab,#docetaxel

Top Word Pairs in Tweet in G4:
[60] 2,kutusu
[60] kutusu,28
[60] 28,bin
[60] bin,tl'den
[60] tl'den,satılan
[60] satılan,ve
[60] ve,ay
[60] ay,kullanılmak
[60] kullanılmak,zorunda
[60] zorunda,opdivo

Top Word Pairs in Tweet in G5:
[7] bristol,myers
[5] myers,squibb
[4] immuno,oncology
[4] bms,opdivo
[4] opdivo,fails
[4] bmsnews,announced
[4] opdivo,nivolumab
[4] nivolumab,opdivo
[4] bempeg,shows
[4] shows,encouraging

Top Word Pairs in Tweet in G6:
[22] checkmate,459
[21] overall,survival
[19] results,checkmate
[19] 459,trial
[19] trial,show
[19] show,nivolumab
[19] nivolumab,improve
[19] improve,overall
[19] survival,compared
[19] compared,sorafenib

Top Word Pairs in Tweet in G7:
[19] bmy,opdivo
[17] opdivo,fails
[15] 1st,line
[13] fails,1st
[12] glioblastoma,tough
[12] tough,cancer
[12] cancer,crack
[12] crack,today
[12] today,s
[12] s,failure

Top Word Pairs in Tweet in G8:
[12] pd,1
[10] bmy,announces
[10] thing,pd
[10] 1,truly
[10] truly,differentiated
[10] differentiated,maybe
[10] maybe,even
[10] even,better
[10] better,crowd
[8] biostocks,bmy

Top Word Pairs in Tweet in G10:
[18] オプジーボの副作用報道,従来も記載
[18] 従来も記載,認識されていた下垂体機能障害を
[18] 認識されていた下垂体機能障害を,重大な副作用
[18] 重大な副作用,に格上げしたものであり
[18] に格上げしたものであり,その頻度の低さ
[18] その頻度の低さ,適切に検査で発見し処置可能であることを考えれば
[18] 適切に検査で発見し処置可能であることを考えれば,その効果を天秤に計ると騒ぎすぎだと感じます
[17] biotechmania,オプジーボの副作用報道

Top Replied-To
Top Replied-To in Entire Graph:
@thenci
@fundacionbadan
@bmsnews
@julioespinoza4
@buscandomedicin
@bradloncar
@medcancervzla
@ca601ff0a58d454
@adamfeuerstein
@ncicancertrials

Top Replied-To in G3:
@fundacionbadan
@buscandomedicin
@medcancervzla
@julioespinoza4
@freddyflash1
@maydavila1
@serviciopublive
@ca601ff0a58d454

Top Replied-To in G4:
@barisyarkadas

Top Replied-To in G5:
@bmsnews
@nektar
@curemelanoma

Top Replied-To in G7:
@adamfeuerstein
@rogerb06385286
@matthewherper
@zbiotech

Top Replied-To in G8:
@bradloncar
@drugchannels
@fiercebiotech
@stockmatusow

Top Replied-To in G9:
@rskemp01
@mikejohansenmd
@akapczynski

Top Mentioned
Top Mentioned in Entire Graph:
@satoruo
@barisyarkadas
@serviciopublive
@ayudasosvzla
@medcancervzla
@donamed_ve
@bmsnews
@sebuscasedona
@buscandomedicin
@sosmedicina

Top Mentioned in G1:
@clinicalphase
@cmencke
@judsontelemed
@ray_noble1
@womens_womens
@nailethv
@lmmarknaden
@larvol
@lungcancer_bio

Top Mentioned in G2:
@satoruo

Top Mentioned in G3:
@serviciopublive
@ayudasosvzla
@medcancervzla
@donamed_ve
@sebuscasedona
@buscandomedicin
@sosmedicina
@publserv
@esedesalud
@medicinasve

Top Mentioned in G4:
@barisyarkadas

Top Mentioned in G5:
@bmsnews
@biotechvisigoth
@xbranebiopharma
@medcitynews
@pharmatimes
@curemelanoma
@nektar
@rightrelevance
@vedantabio
@novartis

Top Mentioned in G6:
@bclc_group
@augustonyc
@aeehliver
@bmsnews
@dufour_jf
@infocancerfoie
@jturnesv
@adiazgonzalezmd

Top Mentioned in G7:
@adamfeuerstein
@johncendpts
@jacobplieth
@endpts
@matthewherper
@jimcramer
@bio_clouseau
@rogerb06385286
@cancer_bio
@zbiotech

Top Mentioned in G8:
@biostocks
@bradloncar
@dewdiligence
@tradertexmex
@semodough
@fiercebiotech
@fezziwig2008
@adamfeuerstein
@altarum
@cmsgov

Top Mentioned in G9:
@vprasadmdmph
@venkmurthy
@oncology_bg
@drjohnm
@cmichaelgibson
@onco_cardiology
@drmarthagulati
@purviparwani
@roguerad
@anish_koka

Top Mentioned in G10:
@biotechmania

Top Tweeters
Top Tweeters in Entire Graph:
@myalliesnews
@follementbijoux
@allstocknews
@rocketnews1
@politicalhedge
@razzletazzlemag
@tradnews_
@marketcurrents
@gogiuk
@newsfromspi

Top Tweeters in G1:
@myalliesnews
@follementbijoux
@allstocknews
@rocketnews1
@politicalhedge
@razzletazzlemag
@marketcurrents
@gogiuk
@newsfromspi
@crweworld

Top Tweeters in G2:
@hayohater
@suigadou
@kumikokatase
@kinginsunago
@kgn_works
@mifasorahula
@socio34050
@aim54_phoenix
@maetaru2
@alcedo_kawasemi

Top Tweeters in G3:
@serviciopublive
@tamaracoromoto
@donamed_ve
@chuotorrealba
@fundatiacruz
@sebuscasedona
@fundacionbadan
@aclave
@ayudasosvzla
@publserv

Top Tweeters in G4:
@barisyarkadas
@no_rumuz
@ezgisutoprak
@sebahatturkmen
@nathan61641442
@fkoruyucu1
@zehrabozca
@keremozbyt
@svmaktryldz
@gollik_emel

Top Tweeters in G5:
@hernangraffe
@pharmaphorum
@ci4cc
@chocolatierep
@medcitynews
@mimigirlsmom
@lizchristensen2
@pharmatimes
@thepharmaletter
@mo7d3del

Top Tweeters in G6:
@fpazgomez
@tamarnegie
@hakosemi
@carmenvcello
@sepdigestiva
@rplanasv
@jturnesv
@drjaviercrespo
@birminghamliver
@maria_var_cal

Top Tweeters in G7:
@cancer_bio
@jimcramer
@matthewherper
@gambiste1
@adamfeuerstein
@bertrandbio
@johncendpts
@everydayfinance
@wboscoho
@zbiotech

Top Tweeters in G8:
@bioportfolio
@blossomvinson
@portefeuillefun
@pnani456
@stockmatusow
@bradloncar
@dhovekamp42
@fezziwig2008
@semodough
@biostocks

Top Tweeters in G9:
@drmarthagulati
@cmichaelgibson
@roguerad
@vprasadmdmph
@venkmurthy
@onco_cardiology
@cdcgov
@oncology_bg
@anish_koka
@purviparwani

Top Tweeters in G10:
@rijin_nakamura
@dominique_domon
@chokosh0120
@kantaiheiyo1
@lapin214_gn
@chemordie
@mori_nobu
@steroidinlondon
@d10868999
@data_tinkerman


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.